Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03224819
Title Study of AMG 673 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | DEU | AUS

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Washington Seattle Washington 98109 United States Details
The Alfred Hospital Melbourne Victoria 3004 Australia Details
The Royal Melbourne Hospital Parkville Victoria 3050 Australia Details
Klinikum der Ludwig Maximilians Univeritaet München 81377 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field